NCT00399438View on ClinicalTrials.gov

A Study of BMS-562086 in Patients With Irritable Bowel Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

January 31, 2008

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Placebo

Tablets, Oral, once daily, 2 weeks

DRUG

BMS-562086

Tablets, Oral, once daily, 2 weeks

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY